| varnimcabtagene autoleucel (ARI-0001) / August Pi i Sunyer Biomedical Research Institute |
2019-003038-17: Phase 2 study of the infusion of ARI-0001 cells in patients with CD19 + acute lymphoid leukemia resistant or refractory to therapy. Estudio fase 2 de la infusión de células ARI-0001 en pacientes con leucemia linfoblástica aguda CD19+ resistente o refractaria a tratamiento. |
|
|
| Not yet recruiting | 2 | 32 | Europe | ARI-0001 Cells, Solution for injection | Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Instituto de Salud Carlos III | CD19+ acute lymphoid leukemia resistant or refractory to treatment Leucemia linfoblástica aguda CD19+ resistente o refractaria a tratamiento, Adult acute lymphoid leukemia resistant or refractory Leucemia linfoblástica aguda en adultos resistente o refractaria, Diseases [C] - Cancer [C04] | | | | |
2021-000937-15: A study evaluating the safety and efficacy of a in-house manufactured CAR T-cell treatment in patients with relapsed/refractory Non-Hodgkin Lymphoma Een onderzoek naar de veiligheid en werkzaamheid van in het ziekenhuis geproduceerde CAR T- cellen als behandeling voor patiënten met een B-cel Non-Hodgkin lymfoom waarbij de ziekte is teruggekeerd of niet heeft gereageerd op de eerdere behandeling(en). |
|
|
| Not yet recruiting | 2 | 300 | Europe | ARI-0001, axicabtagene ciloleucel, ARI-0001, Dispersion for infusion, Yescarta | UMCG, Zorginstituut Nederland | B-Cell Non Hodgkin Lymphoma, B-Cell Non Hodgkin Lymphoma, Diseases [C] - Cancer [C04] | | | | |
2022-001101-52: Phase 2 study of the infusion of ARI-0001 cells in children and adolescents with CD19+ acute lymphoid leukemia resistant or refractory to treatment Estudio fase 2 de la infusión de células aRI-0001 en niños y adolescentes con leucemia linfoblástica aguda CD19+ resistente o refractaria a tratamiento |
|
|
| Not yet recruiting | 2 | 40 | Europe | ARI-0001, Solution for injection, ARI-0001 | Fundació Privada per a la Recerca i la Docència Sant Joan de Déu, ISCIII | CD19+ acute lymphoid leukemia resistant or refractory to treatment Leucemia linfoblástica aguda resistente o refractaria, acute lymphoid leukemia resistant or refractory to treatment Leucemia linfoblástica aguda resistente o refractaria, Diseases [C] - Cancer [C04] | | | | |
CART19-BE-02, NCT04778579: Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy |
|
|
| Active, not recruiting | 2 | 50 | Europe | ARI-0001 cells, CART19, PEI 19-187 | Sara V. Latorre, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Instituto de Salud Carlos III | Acute Lymphoid Leukemia | 12/24 | 12/25 | | |
HOVON161, NCT05641428: Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL |
|
|
| Recruiting | 2 | 300 | Europe | ARI-0001, Axi-cel | University Medical Center Groningen, Stichting Hemato-Oncologie voor Volwassenen Nederland | NHL, DLBCL - Diffuse Large B Cell Lymphoma | 12/25 | 12/27 | | |
| Completed | 1 | 50 | Europe | Adult differentiated autologous T-cells | Sara V. Latorre, Instituto de Salud Carlos III | Leukemia, Lymphoma | 09/22 | 09/22 | | |
